Workboat Indexes
Articles published by LumiraDx Inc
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
January 05, 2024
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
December 29, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub
October 20, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Reports Second Quarter 2023 Results
August 24, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
August 16, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Reports First Quarter 2023 Results
May 16, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16
May 09, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Reports Fourth Quarter and Full Year 2022 Results
March 21, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Regains Compliance with Nasdaq Continued Listing Requirements
February 17, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
January 31, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test
December 14, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
November 14, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx Reports Third Quarter 2022 Results
November 09, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
![](https://ml.globenewswire.com/media/c489706e-9fb7-43b6-8e27-5bb87bf3a0dc/small/lumiradx-logo-blue-horizontal-tm21-png.png)
LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9
November 02, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers
LMDX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.